rs3487348 — PTPN1 PTPN1 LD Block Co-Variant
Intronic PTPN1 variant in the 100-kb haplotype block; T allele associated with more favorable cholesterol profile (lower total and LDL cholesterol) in lean individuals
Details
- Gene
- PTPN1
- Chromosome
- 20
- Risk allele
- G
- Clinical
- Risk Factor
- Evidence
- Moderate
Population Frequency
Category
Blood Sugar & DiabetesSee your personal result for PTPN1
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
PTP1B's Genetic Brake Pedal: How PTPN1 Variants Shape Insulin and Cholesterol
Protein tyrosine phosphatase 1B (PTP1B), encoded by the PTPN1 gene on
chromosome 20q13, acts as a molecular brake on insulin signaling. When
the insulin receptor is activated, it phosphorylates itself on key
tyrosine residues to initiate a signaling cascade that drives glucose
uptake and metabolic regulation.
PTP1B dephosphorylates those same residues11 PTP1B dephosphorylates those same residues
PTP1B is the primary phosphatase
that terminates insulin receptor activation by removing phosphate groups
from pY1158, pY1162, and pY1163 in the kinase activation loop,
terminating the signal. More PTP1B activity means weaker insulin signaling;
less means stronger.
rs3487348 is an intronic variant in the PTPN1 gene body, residing within the well-characterized ~100-kilobase haplotype block that spans most of PTPN1 from the promoter region through intron 8. It is co-listed with rs6020611 in the same LD block — variants in this block do not change the PTP1B protein sequence but are thought to affect transcript levels or stability, altering how much PTP1B the cell produces.
The Mechanism
The PTPN1 intronic haplotype block contains more than 20 common variants
(minor allele frequency >10%) all in strong linkage disequilibrium with
one another. None of these variants changes an amino acid in PTP1B.
The leading hypothesis is that they affect regulatory elements22 regulatory elements
Enhancers,
silencers, or splicing regulatory sequences embedded in the large introns
of PTPN1 that control transcription factor binding or RNA processing
within the introns, altering PTP1B expression level in metabolically
active tissues such as skeletal muscle, liver, and adipose tissue.
rs3487348's T allele is associated with a more favorable lipid profile specifically in lean individuals — lower total cholesterol and LDL cholesterol. This association appears strongest in those with BMI below 26 kg/m². The mechanism connecting PTP1B to lipid regulation involves both the insulin receptor pathway (higher PTP1B activity reduces insulin signaling, which is required for normal hepatic lipid homeostasis) and the leptin receptor pathway (PTP1B also dephosphorylates JAK2, which transmits leptin signaling for appetite and energy balance).
The Evidence
The primary study is Bauer et al. 2010 (PMID 20177231)33 Bauer et al. 2010 (PMID 20177231)
Florianne Bauer
et al. PTPN1 polymorphisms are associated with total and LDL cholesterol.
European Journal of Cardiovascular Prevention & Rehabilitation, 2010.
n=382 Dutch Caucasian men aged 40-80.,
which examined four tag SNPs across the PTPN1 LD block in 382 Dutch men.
The rs3487348 T allele was associated with lower total plasma cholesterol
and LDL cholesterol specifically in men with BMI below 26 kg/m² (P<0.05).
The association was BMI-dependent: the cholesterol effect was not
significant in overweight or obese individuals.
The broader PTPN1 haplotype context comes from
Bento et al. 200444 Bento et al. 2004
Bento JL et al. Association of protein tyrosine
phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes, 2004.
Case-control in two independent Caucasian cohorts; combined n~885.
23 noncoding SNPs across 161 kb.,
which found that the entire 100-kb haplotype block was associated with T2D
risk (OR ~1.3, population-attributable risk 17-20%) in two independent
Caucasian cohorts. The IRAS Hispanic family study
Palmer et al. 200455 Palmer et al. 2004
Palmer ND et al. Association of protein tyrosine
phosphatase 1B gene polymorphisms with measures of glucose homeostasis in
Hispanic Americans (IRAS Family Study). Diabetes, 2004. n=811 across 55 families.
All 20 SNPs with MAF >10% in one haplotype block showed significant
association with insulin sensitivity.
found all 20 common variants in the block associated with insulin sensitivity
index and fasting glucose in Hispanic families.
However, a much larger replication study by
Florez et al. 200566 Florez et al. 2005
Florez JC et al. Association testing of the protein
tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people.
Diabetes, 2005. Power estimated at >95% to detect previously reported ORs.
No significant association found for any SNP or haplotype.
(n=7,883) failed to replicate the T2D association, suggesting the effect
may be population-specific or smaller than initial estimates. This
inconsistency is common in PTPN1 literature across different ethnic groups.
The related variant in the same block, rs3787348, was independently shown by Yamakage et al. 2021 to predict blunted weight-loss response in 447 obese Japanese patients (P=0.001 for BMI reduction).
Practical Actions
For individuals carrying two copies of the G allele at rs3487348, the available evidence suggests mildly elevated LDL and total cholesterol tendency in lean individuals, mediated through PTPN1 expression changes that affect insulin receptor and possibly leptin receptor signaling. The actionable focus is on modulating saturated fat intake and monitoring lipid-relevant biomarkers, since the G allele tags a haplotype pattern linked to less favorable cholesterol profile.
Reducing saturated fat intake is genotype-relevant here: the PTPN1 pathway intersects hepatic fat metabolism, and saturated fat is the primary dietary driver of LDL particle production. This is not generic dietary advice — the specificity is that the PTP1B pathway directly influences hepatic insulin sensitivity and thus LDL receptor activity.
Interactions
rs3487348 is in strong linkage disequilibrium with rs6020611, rs3787348, rs6067484, rs941798, and rs1060402 — all intronic PTPN1 variants in the same 100-kb block. The compound effect of carrying multiple risk alleles across this block may amplify the insulin resistance and dyslipidemia signals beyond what any single variant predicts. The PTPN1 haplotype also interacts with the PTPN2 gene (T-cell protein tyrosine phosphatase), which shares structural homology and partially overlapping substrates; variants in PTPN2 appear in the autoimmune-inflammation category.
Nutrient Interactions
Genotype Interpretations
What each possible genotype means for this variant:
Two T alleles — associated with more favorable cholesterol levels in lean individuals
The TT genotype at rs3487348 sits on the beneficial end of the PTPN1 intronic haplotype spectrum for cholesterol regulation. The T allele tags a haplotype configuration that, in lean Dutch Caucasian men (BMI <26 kg/m²), is associated with significantly lower total plasma cholesterol and LDL cholesterol compared to GG carriers (P<0.05, Bauer et al. 2010).
The mechanism is indirect: the T allele likely tags reduced PTP1B expression in metabolically relevant tissues (liver, skeletal muscle), which maintains stronger insulin receptor phosphorylation. Insulin signaling in the liver directly drives LDL receptor upregulation and hepatic cholesterol clearance — so stronger insulin signaling means more LDL receptors and lower circulating LDL-C.
Importantly, the cholesterol benefit was only statistically significant in lean individuals. In overweight individuals, the excess adiposity likely overrides the genetic effect through other mechanisms (elevated free fatty acids, hepatic steatosis, inflammation).
One G and one T allele — intermediate cholesterol and insulin sensitivity profile
GT heterozygotes carry one copy of the T-tagged PTPN1 haplotype and one copy of the G-tagged risk haplotype. Based on the additive inheritance pattern typical of this locus, the phenotypic effect is intermediate — partially favorable cholesterol regulation relative to GG, but not as favorable as TT. In the Bauer et al. 2010 cohort, heterozygotes were an intermediate group.
For the T2D-related haplotype associations (insulin sensitivity, fasting glucose), heterozygotes in the IRAS Hispanic family study showed intermediate insulin sensitivity index values between the two homozygous groups, consistent with additive effects.
Two G alleles — associated with less favorable cholesterol levels; PTPN1 risk haplotype
GG homozygotes carry two copies of the G-tagged PTPN1 haplotype, which is associated with the least favorable cholesterol profile of the three genotypes in lean men. The G haplotype likely tags higher effective PTP1B expression in liver and skeletal muscle, dampening insulin receptor signaling, which reduces hepatic LDL receptor upregulation and leaves more LDL particles circulating.
The T2D-relevant associations: Bento et al. 2004 found that the PTPN1 risk haplotype (which the G allele tags) was associated with OR ~1.3 for T2D in two independent Caucasian case-control cohorts, with an estimated population-attributable risk of 17-20%. In the IRAS Hispanic family study, all 20 common variants in this block (including rs3487348) showed association with insulin sensitivity index and fasting glucose. However, Florez et al. 2005 could not replicate the T2D association in a larger population (n=7,883), suggesting the effect may be small or population-specific.
The cholesterol association is particularly relevant in lean individuals — the evidence is specifically from men with BMI <26 kg/m². In overweight individuals, the genetic contribution is likely dwarfed by adiposity-driven metabolic changes. Managing body weight is therefore especially important for GG carriers to preserve normal hepatic cholesterol regulation.